Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2015

Open Access 01-12-2015 | Research

Genital ulcer severity score and genital health quality of life in Behçet’s disease

Authors: Amal Senusi, Noha Seoudi, Lesley Ann Bergmeier, Farida Fortune

Published in: Orphanet Journal of Rare Diseases | Issue 1/2015

Login to get access

Abstract

Background

Behçet’s Disease (BD) is a chronic auto-inflammatory, multisystem relapsing/remitting disorder of unknown aetiology. Oro-genital ulceration is a key feature of the disease and has a major impact on the patients’ quality of life. Other clinical manifestations include ocular inflammation, rheumatologic and skin involvement, while CNS and vascular complications can lead to considerable morbidity. The availability of a valid monitoring tool for BD activity is crucial in evaluating the impact of the disease on daily life activity. The aims of this study were to validate a novel tool for monitoring genital ulceration severity in BD and to assess the impact of genital ulcers on the Genital Health Quality of Life (GHQoL).

Methods

Genital Ulcer Severity Score (GUSS) was developed using six genital ulcer characteristics: number, size, duration, ulcer-free period, pain and site. A total of 207 BD patients were examined, (137 females: mean age ± SD: 39.83 ± 13.42 and 70 males: mean age ± SD: 39.98 ± 11.95) from the multidisciplinary Behçet’s Centre of Excellence at Barts Health NHS Trust. GUSS was used in conjunction with Behçet’s Disease Current Activity Form (BDCAF).

Results

The over-all score of GUSS showed a strong correlation with all genital ulcer characteristics, and the strongest correlation was with the pain domain (r = 0.936; P < 0.0001). Ulcer average size and ulcer pain were the major predicting factors in GUSS (β = 0.284; β = 0.275) respectively, and P-values were significant. Multivariate regression analysis indicated that the ulcer pain, size and site are the main ulcer characteristics having an influence on the GHQoL (R2: 0.600; P < 0.0001).

Conclusions

This study established the practicality of GUSS as a severity monitoring tool for BD genital ulcers and validated its use in 207 patients. Genital ulcers of BD have a considerable impact on the patients GHQoL.
Appendix
Available only for authorised users
Literature
5.
go back to reference Faezi ST, Chams-Davatchi C, Ghodsi SZ, Shahram F, Nadji A, Akhlaghi M, et al. Genital aphthosis in Behçet’s disease: Is it associated with less eye involvement? Rheumatol Int. 2014. doi:10.1007/s00296-014-3011-5. Faezi ST, Chams-Davatchi C, Ghodsi SZ, Shahram F, Nadji A, Akhlaghi M, et al. Genital aphthosis in Behçet’s disease: Is it associated with less eye involvement? Rheumatol Int. 2014. doi:10.​1007/​s00296-014-3011-5.
7.
go back to reference Mumcu G. Behçet’s disease: a dentist’s overview. Clin Exp Rheumatol. 2008;26(4 Suppl 50):4. Mumcu G. Behçet’s disease: a dentist’s overview. Clin Exp Rheumatol. 2008;26(4 Suppl 50):4.
8.
go back to reference Lee S. Diagnostic criteria of Behçet’s disease: problems and suggestions. Yonsei Med J. 1997;38(6):365–9.CrossRefPubMed Lee S. Diagnostic criteria of Behçet’s disease: problems and suggestions. Yonsei Med J. 1997;38(6):365–9.CrossRefPubMed
9.
10.
go back to reference International Team for the Revision of the International Criteria for Behçet’s D, Davatchi F, Assaad-Khalil S, Calamia K, Crook J, Sadeghi-Abdollahi B, et al. The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–47. doi:10.1111/jdv.12107.CrossRef International Team for the Revision of the International Criteria for Behçet’s D, Davatchi F, Assaad-Khalil S, Calamia K, Crook J, Sadeghi-Abdollahi B, et al. The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–47. doi:10.​1111/​jdv.​12107.CrossRef
15.
go back to reference Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain A, Gul A, et al. Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis. 2009;68(10):1528–34. doi:10.1136/ard.2008.087957.CrossRefPubMed Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain A, Gul A, et al. Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis. 2009;68(10):1528–34. doi:10.​1136/​ard.​2008.​087957.CrossRefPubMed
16.
go back to reference Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis. 2010;69(10):1744–50. doi:10.1136/ard.2009.119032.CrossRefPubMed Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis. 2010;69(10):1744–50. doi:10.​1136/​ard.​2009.​119032.CrossRefPubMed
18.
go back to reference Zouboulis CC. Epidemiology of Adamantiades-Behcet’s disease. Ann Med Interne. 1999;150(6):488–98. Zouboulis CC. Epidemiology of Adamantiades-Behcet’s disease. Ann Med Interne. 1999;150(6):488–98.
20.
go back to reference Onder M, Gürer M. The multiple faces of Behçet’s disease and its aetiological factors. J Eur Acad Dermatol Venereol. 2001;15(2):126–36.CrossRefPubMed Onder M, Gürer M. The multiple faces of Behçet’s disease and its aetiological factors. J Eur Acad Dermatol Venereol. 2001;15(2):126–36.CrossRefPubMed
21.
go back to reference Alekberova Z, Izmailova F, Kudaev M. Behçet’s disease: clinical and demographic associations. Ter Arkh. 2013;85(5):48–52.PubMed Alekberova Z, Izmailova F, Kudaev M. Behçet’s disease: clinical and demographic associations. Ter Arkh. 2013;85(5):48–52.PubMed
24.
25.
go back to reference Bernabé E, Marcenes W, Mather J, Phillips C, Fortune F. Impact of Behçet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology (Oxford, England). 2010;49(11):2165–71. doi:10.1093/rheumatology/keq251.CrossRef Bernabé E, Marcenes W, Mather J, Phillips C, Fortune F. Impact of Behçet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology (Oxford, England). 2010;49(11):2165–71. doi:10.​1093/​rheumatology/​keq251.CrossRef
26.
go back to reference Naito M, Suzukamo Y, Wakai K, Azechi M, Kaneko F, Nakayama T, et al. One-year period prevalence of oral aphthous ulcers and oral health-related quality of life in patients with Behçet’s disease. Genet Res Int. 2014;2014:8. doi:10.1155/2014/930348. Naito M, Suzukamo Y, Wakai K, Azechi M, Kaneko F, Nakayama T, et al. One-year period prevalence of oral aphthous ulcers and oral health-related quality of life in patients with Behçet’s disease. Genet Res Int. 2014;2014:8. doi:10.​1155/​2014/​930348.
27.
29.
go back to reference World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4):373. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4):373.
31.
go back to reference Wechsler F. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335(8697):1078–80. Wechsler F. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335(8697):1078–80.
33.
36.
go back to reference Khabbazi A, Noshad H, Shayan FK, Kavandi H, Hajialiloo M, Kolahi S. Demographic and clinical features of Behcet’s disease in Azerbaijan. Int J Rheum Dis. 2014. doi:10.1111/1756-185x.12512. Khabbazi A, Noshad H, Shayan FK, Kavandi H, Hajialiloo M, Kolahi S. Demographic and clinical features of Behcet’s disease in Azerbaijan. Int J Rheum Dis. 2014. doi:10.​1111/​1756-185x.​12512.
39.
go back to reference Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A. Development of the BD-QoL: a quality of life measure specific to Behçet’s disease. J Rheumatol. 2004;31(5):931–7.PubMed Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A. Development of the BD-QoL: a quality of life measure specific to Behçet’s disease. J Rheumatol. 2004;31(5):931–7.PubMed
41.
go back to reference Lu M. The influence of age on Behçet’s disease activity. Eurasian J Med. 2008;40(2):68. Lu M. The influence of age on Behçet’s disease activity. Eurasian J Med. 2008;40(2):68.
42.
go back to reference Gül I, Kartalcı Ş, Cumurcu B, Karıncaoğlu Y, Yoloğlu S, Karlıdağ R. Evaluation of sexual function in patients presenting with Behçet’s disease with or without depression. J Eur Acad Dermatol Venereol. 2013;27(10):1244–51. doi:10.1111/j.1468-3083.2012.04698.x.PubMed Gül I, Kartalcı Ş, Cumurcu B, Karıncaoğlu Y, Yoloğlu S, Karlıdağ R. Evaluation of sexual function in patients presenting with Behçet’s disease with or without depression. J Eur Acad Dermatol Venereol. 2013;27(10):1244–51. doi:10.​1111/​j.​1468-3083.​2012.​04698.​x.PubMed
Metadata
Title
Genital ulcer severity score and genital health quality of life in Behçet’s disease
Authors
Amal Senusi
Noha Seoudi
Lesley Ann Bergmeier
Farida Fortune
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2015
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-015-0341-7

Other articles of this Issue 1/2015

Orphanet Journal of Rare Diseases 1/2015 Go to the issue